» » »

Prostate Cancer Screening Celina OH

Prostate cancer screening consists of diagnostic tests that can assist with early detection of prostate cancer. Screening may involve a digital rectal exam, prostate-sspecific antigen (PSA) blood test, or a transrectal ultrasound. See below to learn more and to gain access to qualified oncologists in Celina, OH who provide prostate cancer screening.

Roy Stuart Patten, MD
419-394-6395
1003 S Knoxville Ave
Saint Marys, OH
Roy Patten
419-394-6395
1003 S Knoxville Ave
Saint Marys, OH
Robert Alan Baiocchi, MD
614-293-6154
Sterling Loving Hall 320 W 10th Ave A437
Columbus, OH
Brenda W Cooper
(216) 844-8500
11100 Euclid Ave
Cleveland, OH
Heath B Mackley, MD
216-444-2200
9500 Euclid Ave
Cleveland, OH
Ashok Tripuraneni
(419) 394-2724
1004 Knoxville Ave
St. Marys, OH
Gary Lewis Nicholson, MD
937-293-1622
3120 Governors Place Blvd
Dayton, OH
Earl N Metz, MD
614-293-8725
226 E Dublin Granville Rd
Worthington, OH
Richard R Love
(614) 798-7905
300 W 10th Ave
Columbus, OH
John Charles Breneman, MD
513-584-4775
234 Goodman St
Cincinnati, OH
Data Provided by:
  

All about the PSA Test

The PSA (Prostate-Specific Antigen) test is one of two primary screening tools for prostate cancer. This simple blood test measures the level of PSA, a protein produced in the prostate, present in a man's body. Men typically have an initial PSA screening at 50, or earlier if there's a family history of prostate cancer.

Physicians measure PSA in nanograms per milliliter. An elevated PSA doesn't diagnose cancer and doesn't mean a man has prostate cancer; it just suggests further evaluation. Other medical conditions can also raise PSA levels. A PSA test and additional diagnostic tools help detect small tumors, however, experts say it does not necessarily reduce a man's chance of dying of prostate cancer.

An increase in PSA is the strongest single predictor of prostate cancer risk, and a high PSA score followed by a lower PSA score is not uncommon, even in men who do have cancer. However, PSA progression does predict poor overall survival rates in men with mestacized prostate cancer (meaning it has spread beyond the prostate). The PSA test is actually a better predictor of prostate cancer risk in African-American men with family histories compared to European- American men.

There is controversy over the value of PSA screenings. This spring, researchers released the results of a large-scale study that began in 1992 to evaluate whether or not the PSA test benefited men. In the subsequent media coverage of the results, the news varied widely depending on who was doing the reporting...

Click here to read more from Quality Health